Medable Inc.
Location
California
Founded
2012-02-26
Website
Risk Signals
29 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Prepackaged Software), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Medable Inc.
Live alerts from global media, monitored by Business Radar
2022-09-08 (fiercebiotech.com)
GSK taps Medable for decentralized clinical trials, patient diversity
GlaxoSmithKline inked trial software firm Medable to a
Read more
(dicardiology.com)
Virtual Study to Track Statin-Related Adverse Events Being Undertaken by University of Connecticut and Hartford Healthcare |
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have selected the Medable Inc. cloud-based clinical trial platform to evaluate statin-related adverse events. It will use electronic patient-reported outcomes in a digital trial. The collaborative digital study is intended to prospectively monitor participant response to statin medications via an app, and notify clinicians and patients when the patient should stop or start their medication based on presenting symptoms collected via electronic patient-reported outcomes (ePROs). The app seeks to use this methodology to identify statin-intolerant individuals in the study, by assessing the pattern, location and timing of their muscle symptoms. Statins, such as Lipitor and Crestor are some of the most widely used drugs in the world, due to their effectiveness for reducing cholesterol and resultantly, cardiovascular disease (CVD) mortality and events. Although statins are widely available, cost-effective
Read more